Cancer Research

Background: Federal investment in cancer research has played a role in every major innovation in the fight against cancer and has led to a decline in mortality rates for many cancers. As the American research pipeline continues to recover from the negative impacts of the COVID-19 pandemic, ASTRO remains focused on securing meaningful funding increases for cancer research at the National Institutes of Health (NIH) and National Cancer Institute (NCI).

Our FY24 Asks:

  • At least $51 billion for NIH in FY24, about a $3.5 billion increase from FY23.
  • $9.988 billion for NCI, a $2.6 billion increase from FY23 and the amount proposed by NCI in its FY24 professional judgement budget.
  • At least $1.5 billion for the new Advanced Research Projects Agency for Health (ARPA-H).
  • $536.4 million for the CDC Division of Cancer Prevention and Control.